Ring-opening polymerization of ε-caprolactone initiated by the antitumor agent doxifluridine
Authors:
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 5 (4) , 1075-1081
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- HPMA Copolymer-1,5-Diazaanthraquinone Conjugates as Novel Anticancer TherapeuticsJournal of Drug Targeting, 2004
- Polymeric anticancer drugs with pH-controlled activationAdvanced Drug Delivery Reviews, 2004
- Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate2004
- HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemiaJournal of Controlled Release, 2003
- Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomesJournal of Controlled Release, 2001
- New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological propertiesJournal of Controlled Release, 2001
- Poly(ethylene glycol) Multiblock Copolymer as a Carrier of Anti-Cancer Drug DoxorubicinBioconjugate Chemistry, 2000
- New derivatives of polyglutamic acid as drug carrier systemsJournal of Controlled Release, 2000
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992